Granite Investment Partners’s RxSight RXST Stock Holding History

Granite Investment Partners’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-312,574	Closed	-$7.89M	–	278
2025 Q1	$7.89M	Buy	312,574 +131,243	+72%	+$3.9M	0.4%	87
2024 Q4	$6.23M	Sell	181,331 -4,903	-3%	-$221K	0.27%	109
2024 Q3	$9.21M	Sell	186,234 -14,303	-7%	-$733K	0.39%	91
2024 Q2	$12.1M	Sell	200,537 -23,965	-11%	-$1.37M	0.5%	71
2024 Q1	$11.6M	Sell	224,502 -6,425	-3%	-$315K	0.44%	78
2023 Q4	$9.31M	Buy	+230,927	New	+$6.77M	0.36%	85

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Granite Investment Partners's RXST Position: Q2 2025 in Review

Granite Investment Partners sold out of RxSight (RXST) in Q2 2025, closing a stake of 312,574 shares — an estimated $7.89M sold.

Granite Investment Partners first reported a position in RXST in Q4 2023 and held it in 6 quarters. The position peaked at $12.1M in Q2 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

Granite Investment Partners reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
Granite Investment Partners sold 312,574 RxSight shares in Q2 2025, an estimated $7.89M.
Granite Investment Partners first reported a position in RxSight in Q4 2023 and held it in 6 quarters.
Granite Investment Partners's RxSight position peaked at $12.1M in Q2 2024.
174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on Granite Investment Partners's 13F filing for Q2 2025, filed 13 Aug 2025.